Author Question: Most marriage counselors are opposed to no-power relationships. a. True b. False Indicate ... (Read 70 times)

jlmhmf

  • Hero Member
  • *****
  • Posts: 552
Most marriage counselors are opposed to no-power relationships.
 
  a. True
 b. False
  Indicate whether the statement is true or false

Question 2

Which of the following reasons is espoused by your textbook as a good reason for ending a relationship?
 
  a. If the relationship has become too much work and not enough play.
 b. When you start to feel uncomfortable with the level of commitment, or scared of increasing intimacy.
 c. If your partner is too different from you in terms of economic background.
 d. When the relationship is characterized by violence or consistent verbal abuse.



Fayaz00962

  • Sr. Member
  • ****
  • Posts: 330
Answer to Question 1

False

Answer to Question 2

d



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
 

Did you know?

Computer programs are available that crosscheck a new drug's possible trade name with all other trade names currently available. These programs detect dangerous similarities between names and alert the manufacturer of the drug.

Did you know?

A serious new warning has been established for pregnant women against taking ACE inhibitors during pregnancy. In the study, the risk of major birth defects in children whose mothers took ACE inhibitors during the first trimester was nearly three times higher than in children whose mothers didn't take ACE inhibitors. Physicians can prescribe alternative medications for pregnant women who have symptoms of high blood pressure.

Did you know?

Liver spots have nothing whatsoever to do with the liver. They are a type of freckles commonly seen in older adults who have been out in the sun without sufficient sunscreen.

Did you know?

Approximately 15–25% of recognized pregnancies end in miscarriage. However, many miscarriages often occur before a woman even knows she is pregnant.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

For a complete list of videos, visit our video library